ArticleCancers2024

Lazertinib versus Platinum-Based Chemotherapy with Epidermal Growth Factor Receptor (EGFR)-Positive Non-Small-Cell Lung Cancer after Failing EGFR-Tyrosine Kinase Inhibitor: A Real-World External Comparator Study.

Junho Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.